Teva announces exclusive launch of generic Axiron® in the U.S.
Teva announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. Axiron® had annual sales of approximately $247 million in the U.S., according to IMS data as of May 2017. August 18, 2017